Maternal Gestational Weight Gain in Relation to Antidepressant Continuation in Pregnancy

Author:

Wartko Paige D.12ORCID,Weiss Noel S.13,Enquobahrie Daniel A.1,Chan Kwun Chuen Gary4,Stephenson-Famy Alyssa5ORCID,Mueller Beth A.13,Dublin Sascha12

Affiliation:

1. Department of Epidemiology, University of Washington, Seattle, Washington

2. Kaiser Permanente Washington Health Research Institute, Seattle, Washington

3. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

4. Department of Biostatistics, University of Washington, Seattle, Washington

5. Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington

Abstract

Objective Both excessive and inadequate gestational weight gain (GWG) are associated with adverse health outcomes for the woman and her child. Antidepressant use in pregnancy could affect GWG, based on evidence in nonpregnant women that some antidepressants may cause weight gain and others weight loss. Previous studies of antidepressant use and GWG were small with limited ability to account for confounding, including by maternal mental health status and severity. We assessed the association of antidepressant continuation in pregnancy with GWG among women using antidepressants before pregnancy. Study Design Our retrospective cohort study included singleton livebirths from 2001 to 2014 within Kaiser Permanente Washington, an integrated health care system. Data were obtained from electronic health records and linked Washington State birth records. Among women with ≥1 antidepressant fill within 6 months before pregnancy, women who filled an antidepressant during pregnancy were considered “continuers;” women without a fill were “discontinuers.” We calculated mean differences in GWG and relative risks (RR) of inadequate and excessive weight gain based on Institute of Medicine guidelines. Using inverse probability of treatment weighting with generalized estimating equations, we addressed differences in maternal characteristics, including mental health conditions. Results Among the 2,887 births, 1,689 (59%) were to women who continued antidepressants in pregnancy and 1,198 (42%) were to discontinuers. After accounting for confounding, continuers had similar weight gain to those who discontinued (mean difference: 1.3 lbs, 95% confidence interval [CI]: −0.1 to 2.8 lbs) and similar risks of inadequate and excessive GWG (RR: 0.95, 95% CI: 0.80–1.14 and RR: 1.06, 95% CI: 0.98–1.14, respectively). Findings were comparable for specific antidepressants and trimesters of exposure. Conclusion We did not find evidence that continuation of antidepressants in pregnancy led to differences in GWG. Key Points

Publisher

Georg Thieme Verlag KG

Subject

Obstetrics and Gynaecology,Pediatrics, Perinatology, and Child Health

Reference40 articles.

1. National trends in antidepressant medication treatment among publicly insured pregnant women;K F Huybrechts;Gen Hosp Psychiatry,2013

2. Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008;A A Mitchell;Am J Obstet Gynecol,2011

3. Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies;R M Hayes;Am J Obstet Gynecol,2012

4. Antidepressants and body weight: a comprehensive review and meta-analysis;A Serretti;J Clin Psychiatry,2010

5. The efficacy, tolerability, and safety of contemporary antidepressants. The Journal of clinical psychiatry;G I Papakostas,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3